Clinical Trial Update: Efficacy and Cost of State Quitline Policies [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and cost-effectiveness of state quitline policies for smoking cessation; sponsor Kaiser Permanente; study status completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tobacco Use Disorder

Snippet

Sponsor: Kaiser Permanente | Conditions: Smoking Cessation, Tobacco Use Cessation | Phase 3 | Status: COMPLETED